459 computer-programmer-"https:"-"FEMTO-ST"-"Inserm"-"UCL" "https:" "https:" "https:" "https:" "CNRS" positions at Harvard University
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
payment models (e.g., Accountable Care Organizations and bundled payment Initiatives) on healthcare value and equity for older adults Changing market dynamics of the growing Medicare Advantage program
-
and campus) can grow in her or his area of expertise as well as building strong people and project management skills. Learn more here: https://itacademy.harvard.edu/ . Qualifications Basic
-
determined by the number of years post PhD, can be found at https://postdoc.hms.harvard.edu/guidelines Minimum Number of References Required 1 Maximum Number of References Allowed 4 Keywords immunology
-
Research Assistant II to significantly contribute to a research program funded by the Welcome Leap, “The missed vital sign”, involving the use of human Organ Chips to advance knowledge and development
-
regarding postdoctoral fellow salary, which is determined by the number of years post PhD, can be found at https://postdoc.hms.harvard.edu/guidelines Minimum Number of References Required 1 Maximum Number
-
at https://postdoc.hms.harvard.edu/guidelines . Minimum Number of References Required 3 Maximum Number of References Allowed 5 Keywords
-
and Sciences (FAS) is the historic heart of Harvard University. It is the home of Harvard’s undergraduate program (Harvard College, founded in 1636) as well as all of Harvard’s Ph.D. programs
-
salaried and benefits eligible. Information regarding postdoctoral fellow salary, which is determined by the number of years post PhD, and benefits can be found at https://postdoc.hms.harvard.edu/guidelines
-
determined by the number of years post PhD, can be found at https://postdoc.hms.harvard.edu/guidelines Minimum Number of References Required 1 Maximum Number of References Allowed 4 Keywords immunology, cell
-
breakthroughs. We are on a mission to develop a first-in-class therapeutic antibody that has the promise to target a wide range of devastating metabolic diseases. As we prepare to advance our program to IND